Techno Medical PCLBKK:TM +1.08%74 EBITDA Margin % is 11.63% as of Mar. 2026, which is 16% above its 10-year median of 10.02. GuruFocus rates BKK:TM with a GF Score™ of 74/100 and a GF Value™ of ฿1.20 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Techno Medical PCL ranks better than 78.15% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Techno Medical PCL's EBITDA for the
three
months ended in Mar. 2026 was ฿21.3 Mil. Techno Medical PCL's Revenue for the
three
months ended in Mar. 2026 was ฿182.7 Mil. Therefore, Techno Medical PCL's EBITDA margin for the quarter that ended in Mar. 2026 was 11.63%.
Techno Medical PCL (BKK:TM) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Techno Medical PCL EBITDA Margin % Related Terms
Techno Medical PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TM vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Techno Medical PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medical PCL (BKK:TM) has a EBITDA Margin % of 11.63% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Techno Medical PCL and its competitors. This is 16% above median its historical median of 10.02. Over the past decade, Techno Medical PCL's EBITDA Margin % has ranged from 4.40 to 13.08. According to the industry distribution chart, Techno Medical PCL ranks #26 out of 119 companies in the Medical Distribution industry, placing it in the top 21.8%.
Is Techno Medical PCL's EBITDA Margin % too high?
Techno Medical PCL's current EBITDA Margin % of 11.63% is 16% above median its 10-year median of 10.02. Over the past 10 years, this metric has ranged from a low of 4.40 to a high of 13.08. The Medical Distribution industry median EBITDA Margin % is 4.31. Techno Medical PCL's value of 11.63% is 169.8% above this industry median. Based on the distribution chart, Techno Medical PCL ranks #26 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Techno Medical PCL has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #26 out of 119 companies for EBITDA Margin %. This places Techno Medical PCL in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.31. Techno Medical PCL's value of 11.63% is 169.8% above this benchmark. Historically, Techno Medical PCL's own EBITDA Margin % has ranged from 4.40 to 13.08 over the past decade. While the company's 10-year median is 10.02 vs. the industry median of 4.31, Techno Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current EBITDA Margin % of 11.63% is 169.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Techno Medical PCL and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current EBITDA Margin % is 11.63%, which is 16% above median its own 10-year median of 10.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Techno Medical PCL (BKK:TM) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.20, compared to a current price of ฿0.94 — trading 21.7% below its estimated fair value. The current EBITDA Margin % is 11.63%, which is 16% above median its 10-year median of 10.02 and 169.8% above the Medical Distribution industry median of 4.31. Techno Medical PCL's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM), the current EBITDA Margin % is 11.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿0.94 is trading 21.7% below its estimated GF Value™ of ฿1.20.
GuruFocus considers Techno Medical PCL to be Modestly Undervalued.
Key valuation signals for BKK:TM:
EBITDA Margin %: 11.63% (16% above median its 10-year median of 10.02)
GF Value™: ฿1.20 vs. price of ฿0.94 (21.7% below fair value)
Industry Position: 169.8% above the Medical Distribution median (#26 of 119)
No single metric tells the full story. See the BKK:TM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
74GF Score
Get the complete analysis for BKK:TM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM has been successfully added to your 
